Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Applied Dna Scns
(NQ:
APDN
)
2.510
-0.240 (-8.73%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Applied Dna Scns
< Previous
1
2
3
4
Next >
Applied DNA and EvviVax Announce Peer-Reviewed Publication of Positive Preclinical Data for LinearDNA™ Platform as a Novel Cancer Vaccine Strategy in the Journal of Experimental & Clinical Cancer Research
June 06, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
May 09, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Awarded NYC-Based ‘Return-to-Office’
April 06, 2022
From
Applied DNA Sciences, Inc
Via
Business Wire
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
March 23, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
March 14, 2022
From
Applied DNA Sciences, Inc. and Spindle Biotech Inc.
Via
Business Wire
InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering
March 11, 2022
Via
Investor Brand Network
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 24, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
February 22, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
February 17, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
February 10, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
February 03, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
January 28, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
January 21, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
January 18, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
January 04, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
December 15, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing
December 09, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
December 06, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021
December 03, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit
November 29, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer
November 15, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
November 09, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
October 25, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing
November 05, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain
October 20, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College
October 12, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers
September 27, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
September 14, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform
September 08, 2021
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.